Effect of Gallic acid in potentiating chemotherapeutic effect of Paclitaxel in HeLa cervical cancer cells

被引：72

作者：

Aborehab, Nora M. ^{[1
]}

Osama, Nada ^{[2
]}

机构：

[1] October Univ Modern Sci & Arts, MSA Univ, Fac Pharm, Dept Biochem, Giza 12611, Egypt

[2] Menoufia Univ, Fac Pharm, Dept Biochem, Menoufia 32511, Egypt

来源：

CANCER CELL INTERNATIONAL | 2019年 / 19卷 / 1期

关键词：

HeLa cells; Gallic acid; Paclitaxel; P53; Caspase; 3; NATURAL-PRODUCTS; BREAST-CANCER; CYCLE ARREST; CISPLATIN; APOPTOSIS; CARBOPLATIN; GROWTH; DEATH; ERK; PROLIFERATION;

D O I：

10.1186/s12935-019-0868-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BackgroundCervical cancer is the fourth most common cancer affecting women worldwide. Paclitaxel/Carboplatin is one of the most commonly prescribed regimens in cervical cancer treatment. Although chemotherapeutic drugs are very effective, severe side effects and development of drug resistance limits the use of these drugs. The use of natural products with anticancer activity may help to partially overcome these issues.MethodsIn the present study, we investigated the ability of Gallic acid, to potentiate the anti-cancer effects of Paclitaxel, Carboplatin and Paclitaxel/Carboplatin combination in human HeLa cells by performing MTT assay, cell cycle analysis and RT-PCR assay and Western blotting for some apoptotic markers.ResultsOur results revealed that the highest cytotoxic effect, the highest induction of apoptosis and significant elevation in P53 and Caspase 3 levels was seen in Paclitaxel/Gallic acid combination.ConclusionThese results indicate that Gallic acid potentiates Paclitaxel effect and that Paclitaxel/Gallic acid combination could represent a promising alternative with lower side effects-for Paclitaxel/Carboplatin combination in treatment of cervical cancer treatment.

引用

页数：13

共 48 条

[41] Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway [J].

Wang, Ruixuan ;

Ma, Lijie ;

Weng, Dan ;

Yao, Jiahui ;

Liu, Xueying ;

Jin, Faguang .

ONCOLOGY REPORTS, 2016, 35 (05) :3075-3083

[42] Opportunities for natural products in 21st century antibiotic discovery [J].

Wright, Gerard D. .

NATURAL PRODUCT REPORTS, 2017, 34 (07) :694-701

[43] The structural modification of natural products for novel drug discovery [J].

Yao, Hong ;

Liu, Junkai ;

Xu, Shengtao ;

Zhu, Zheying ;

Xu, Jinyi .

EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (02) :121-140

[44] Prooxidant action of gallic acid compounds:: copper-dependent strand breaks and the formation of 8-hydroxy-2′-deoxyguanosine in DNA [J].

Yoshino, M ;

Haneda, M ;

Naruse, M ;

Htay, HH ;

Iwata, S ;

Tsubouchi, R ;

Murakami, K .

TOXICOLOGY IN VITRO, 2002, 16 (06) :705-709

[45] Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion [J].

You, Bo Ra ;

Kim, Sung Zoo ;

Kim, Suhn Hee ;

Park, Woo Hyun .

MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 357 (1-2) :295-303

[46] Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase [J].

You, Bo Ra ;

Park, Woo Hyun .

TOXICOLOGY IN VITRO, 2010, 24 (05) :1356-1362

[47] Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis [J].

You, Bo Ra ;

Moon, Hwa Jin ;

Han, Yong Hwan ;

Park, Woo Hyun .

FOOD AND CHEMICAL TOXICOLOGY, 2010, 48 (05) :1334-1340

[48] Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells [J].

Zhao, Bing ;

Hu, Mengcai .

ONCOLOGY LETTERS, 2013, 6 (06) :1749-1755

← 1 2 3 4 5 →